BioLineRx (BLRX) Assets Average (2023 - 2025)
Historic Assets Average for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $41.5 million.
- BioLineRx's Assets Average fell 2920.37% to $41.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.5 million, marking a year-over-year decrease of 2920.37%. This contributed to the annual value of $51.4 million for FY2024, which is N/A changed from last year.
- As of Q3 2025, BioLineRx's Assets Average stood at $41.5 million, which was down 2920.37% from $43.4 million recorded in Q2 2025.
- In the past 5 years, BioLineRx's Assets Average ranged from a high of $63.8 million in Q2 2023 and a low of $41.2 million during Q1 2025
- Moreover, its 3-year median value for Assets Average was $56.8 million (2023), whereas its average is $52.5 million.
- In the last 5 years, BioLineRx's Assets Average skyrocketed by 496.19% in 2024 and then tumbled by 2920.37% in 2025.
- BioLineRx's Assets Average (Quarter) stood at $58.4 million in 2023, then dropped by 21.52% to $45.8 million in 2024, then decreased by 9.36% to $41.5 million in 2025.
- Its Assets Average was $41.5 million in Q3 2025, compared to $43.4 million in Q2 2025 and $41.2 million in Q1 2025.